REPUTATION CHECK: Will Seroxat scandal damage GSK?
By Claire Murphy, PR Week UK, 27 March 2008, 10:05am
GlaxoSmithKline has escaped prosecution over Seroxat, but the public may not be not so forgiving.
Share this story
To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content. View our subscription and registration options.









